Caplight Directory>Companies>Kind Pharmaceuticals-preview>Kind-pharmaceutical


Kind Pharmaceuticals

Kind Pharmaceuticals

Private
Hangzhou, ZhejiangHealthcare & Life Scienceswww.kindpharmaceutical.com

Last Round

Series C

Nov 12, 2025

Total Funding Raised

$141.5M

Company Overview

Kind Pharmaceutical is a biopharmaceutical company focused on developing innovative drugs and treatments for kidney disease and cancer.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

HIF-PH inhibitorsmall molecule drugsCKD anemiaantibody-drug conjugatesADCsoncologytargeted therapyselective estrogen receptor degraderSERDbiologicsHIF-2 inhibitorclinical-stage pharmadrug developmentrenal cell carcinomakidney canceroral therapieschronic kidney disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kind Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kind Pharmaceuticals Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CNov 12, 2025
View all Funding Rounds

Kind Pharmaceuticals Investors

Notable investors and investment history

InvestorRounds
Northern Light Venture CapitalSeries C, Series B
Decheng CapitalSeries B, Series A
C&D Emerging Industry Equity InvestmentSeries C
Efung CapitalSeries B, Series C
Taiping Healthcare FundSeries C
Gaorong CapitalSeries C, Series B
View all Investors

Kind Pharmaceuticals Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kind Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kind Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou, Zhejiang
Year Founded2014
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.